13F Pro13F Pro

Atalaya Capital Management LP

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1812285
Institutional-grade research for retail investors

Sector Allocation

  • Healthcare47.4%$21.6M
  • Industrials22.5%$10.2M
  • Other13.9%$6.3M
  • Materials12.4%$5.6M
  • Financials3.8%$1.7M
  • Technology0.1%$20,500
  • Consumer Discretionary0.0%$12,333
  • Consumer Staples0.0%$9,000

AUM History

13fpro.ai/research/fund/atalaya-capital-management-lp-1812285

Largest positions — Q2 2024

  • ROIVROIV
    $18.1M
  • LNZALNZA
    $5.4M
  • CNDTCNDT
    $5.1M
  • HLLYHLLY
    $3.7M
  • AEONAEON
    $3.3M
  • MULTIPLAN
    $1.4M
  • BERENSON
    $1.0M
  • PAYOPAYO
    $980K
  • PWPPWP
    $890K
  • AFRICAN
    $837K
  • SHFSSHFS
    $820K
  • MARBLEGATE
    $630K
  • ZALATORIS
    $572K
  • BYNORDIC
    $549K
  • SOUTHLAND
    $293K
  • SLNDSLND
    $242K
  • NBNB
    $227K
  • SYNTEC
    $129K
  • LVWRLVWR
    $95K
  • TERRAN
    $90K

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/atalaya-capital-management-lp-1812285

Atalaya Capital Management LP 13F holdings — Q2 2024

$45.5M portfolio (-46.9% QoQ) · 96 holdings · Q2 2024 13F · top 10 are 90% of the stock portfolio

All holdings — Atalaya Capital Management LP (Q2 2024)

96 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.

Company
SHFS$SHFSSHF Holdings, Inc.$820K—
— MARBLEGATE ACQUISITION CORP$630K—
— ZALATORIS ACQUISITION CORP$572K—
— BYNORDIC ACQUISITION CORP$549K—
— SOUTHLAND HLDGS INC$293K—
SLND$SLNDSouthland Holdings, Inc.$242K—
NB$NBNIOCORP DEVELOPMENTS LTD$227K+182%
— SYNTEC OPTICS HLDGS INC$129K—
LVWR$LVWRLiveWire Group, Inc.$95K—
— TERRAN ORBITAL CORPORATION$90K—
— PROJECT ENERGY REIMAGINED AC$89K—
— ARMADA ACQUISITION CORP I$84K—
DRTS$DRTSAlpha Tau Medical Ltd.$69K-63%
DRTS$DRTSAlpha Tau Medical Ltd.$59K—
ACHR$ACHRArcher Aviation Inc.$56K—

What changed in Q2 2024

Against the previous quarter's 13F: 1 new, 5 added to, 3 trimmed, 19 sold out. Share-count changes; largest moves by dollar size first.

New positions (1)

  • HOLDCO NUVO GROUP D G LTD$3K

    first bought this quarter

Added to (5)

  • ROIV$ROIVRoivant Sciences Ltd.+4476%

    now $18.1M · held 2+ qtrs

  • HLLY$HLLYHolley Inc.+25%

    now $3.7M · held 2+ qtrs

  • NB$NBNIOCORP DEVELOPMENTS LTD+182%

    now $227K · held 2+ qtrs

  • ZAPP ELEC VEHS GROUP LTD+186%

    now $35K

+1 more in the Excel export

Trimmed (3)

  • DRTS$DRTSAlpha Tau Medical Ltd.-63%

    now $69K · held 2+ qtrs

  • CERO THERAPEUTICS HLDGS INC-0.0%

    now $8K

+1 more in the Excel export

Sold out (19)

  • PROSHARES TRwas $13.5M
  • METALS ACQUISITION LIMITEDwas $1.6M
  • METALS ACQUISITION LIMITEDwas $1.4M
  • OIO$OIOOIO Groupwas $414K

    held 1+ qtrs

  • ENGN$ENGNenGene Therapeutics Inc.was $347K
  • SOC$SOCSable Offshore Corp.was $258K

+13 more in the Excel export

Holdings by quarter

Every 13F Atalaya Capital Management LP has filed, 14 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Is it too late to follow Atalaya Capital Management?

Holdings as of Jun 30, 2024 (SEC filing). Prices are closing prices as of Oct 27, 2026.

Average quality of Atalaya Capital Management's top 20 holdings: 39/100 (our AI quality score, weighted by position size; 12 of the 20 are scored)

Top 10 since quarter-end

+120.1%

Value-weighted move of the 10 largest stock positions

Turnover

28%

Last quarter

Top 10 weight

90%

Share of the stock portfolio in its 10 largest positions

Held 4+ quarters

0%

Share of portfolio value in positions held a year or more

Highest-quality names it owns(among its 100 largest positions)

The 8 highest-scoring companies in this portfolio are a Pro feature.

How these are measured
  • Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
  • Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
  • Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q1 2024 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
  • Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
  • Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.

Portfolio Overview

Atalaya Capital Management LP disclosed 96 positions worth $45.5M in its Form 13F-HR for Q2 2024, led by $ROIV (Roivant Sciences Ltd.) at 39.8% of the equity portfolio, followed by $LNZA and $CNDT. During the quarter the fund opened 1 new position and exited 19. The portfolio is most concentrated in Healthcare (47.4% of disclosed assets). All figures are sourced directly from Atalaya Capital Management LP’s Form 13F-HR filing with the SEC under CIK 1812285.

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: Atalaya Capital Management LP

13F Pro is an AI hedge fund tracker and stock research platform. For Atalaya Capital Management LP (SEC CIK: 1812285), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in Atalaya Capital Management LP's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.